• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床上无功能垂体瘤起源于单克隆。

Clinically nonfunctioning pituitary tumors are monoclonal in origin.

作者信息

Alexander J M, Biller B M, Bikkal H, Zervas N T, Arnold A, Klibanski A

机构信息

Division of Medicine, Massachusetts General Hospital, Boston 02114.

出版信息

J Clin Invest. 1990 Jul;86(1):336-40. doi: 10.1172/JCI114705.

DOI:10.1172/JCI114705
PMID:1973174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC296726/
Abstract

Clinically nonfunctioning pituitary adenomas are benign neoplasms comprising approximately 25-30% of pituitary tumors. Little is known about the pathogenesis of pituitary neoplasia. Clonal analysis allows one to make the important distinction between a polyclonal proliferation in response to a stimulatory factor versus a monoclonal expansion of a genetically aberrant cell. We investigated the clonal origin of pituitary tumors using X-linked restriction fragment length polymorphisms at the phosphoglycerate kinase and hypoxanthine phosphoribosyl-transferase genes. Restriction enzymes were used to distinguish maternal and paternal X-chromosomes, and combined with a methylation-sensitive restriction enzyme to analyze allelic X-inactivation patterns in six pituitary adenomas. All six tumors showed a monoclonal pattern of X-inactivation. These data indicate that nonfunctioning pituitary adenomas are unicellular in origin, a result consistent with the hypothesis that this tumor type is due to somatic mutation.

摘要

临床上无功能垂体腺瘤是良性肿瘤,约占垂体肿瘤的25% - 30%。垂体肿瘤的发病机制知之甚少。克隆分析能够在因刺激因子引起的多克隆增殖与基因异常细胞的单克隆扩增之间做出重要区分。我们利用磷酸甘油酸激酶和次黄嘌呤磷酸核糖转移酶基因处的X连锁限制性片段长度多态性来研究垂体肿瘤的克隆起源。使用限制性内切酶区分母本和父本X染色体,并结合甲基化敏感的限制性内切酶分析6例垂体腺瘤中的等位基因X失活模式。所有6个肿瘤均显示出X失活的单克隆模式。这些数据表明,无功能垂体腺瘤起源于单细胞,这一结果与该肿瘤类型是由体细胞突变引起的假说一致。

相似文献

1
Clinically nonfunctioning pituitary tumors are monoclonal in origin.临床上无功能垂体瘤起源于单克隆。
J Clin Invest. 1990 Jul;86(1):336-40. doi: 10.1172/JCI114705.
2
Clonal origin of pituitary adenomas.垂体腺瘤的克隆起源。
J Clin Endocrinol Metab. 1990 Dec;71(6):1427-33. doi: 10.1210/jcem-71-6-1427.
3
Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis.库欣病患者垂体腺瘤的克隆组成:通过X染色体失活分析确定
J Clin Endocrinol Metab. 1991 Dec;73(6):1302-8. doi: 10.1210/jcem-73-6-1302.
4
Clonal composition of benign and malignant human thyroid tumors.良性和恶性人类甲状腺肿瘤的克隆组成。
J Clin Invest. 1990 Jul;86(1):120-5. doi: 10.1172/JCI114673.
5
Clonal analysis of human adrenocortical carcinomas and secreting adenomas.人类肾上腺皮质癌和分泌性腺瘤的克隆分析。
Clin Endocrinol (Oxf). 1994 Apr;40(4):465-77. doi: 10.1111/j.1365-2265.1994.tb02485.x.
6
Clonal composition of human adrenocortical neoplasms.人类肾上腺皮质肿瘤的克隆组成。
Cancer Res. 1994 Sep 15;54(18):4927-32.
7
Clonal analysis of solitary follicular nodules in the thyroid.甲状腺单个滤泡结节的克隆分析
Am J Pathol. 1990 Sep;137(3):553-62.
8
Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene.骨髓发育异常患者中粒细胞和单核细胞的克隆性受累,而非T和B淋巴细胞及自然杀伤细胞:通过X连锁限制性片段长度多态性和磷酸甘油酸激酶基因的聚合酶链反应进行分析
Blood. 1992 Oct 1;80(7):1774-80.
9
Clonal composition of glioblastoma multiforme.多形性胶质母细胞瘤的克隆组成。
J Neurosurg. 1992 Sep;77(3):432-7. doi: 10.3171/jns.1992.77.3.0432.
10
Clonal analysis using recombinant DNA probes from the X-chromosome.使用来自X染色体的重组DNA探针进行克隆分析。
Cancer Res. 1987 Sep 15;47(18):4806-13.

引用本文的文献

1
Association between Intracellular Calcium Signaling and Tumor Recurrence in Human Non-Functioning Pituitary Adenomas.细胞内钙信号与人类无功能垂体腺瘤肿瘤复发的关系。
Int J Mol Sci. 2024 Apr 3;25(7):3968. doi: 10.3390/ijms25073968.
2
Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2.无明显谱系分化的垂体肿瘤表达干细胞标志物 SOX2。
Pituitary. 2024 Jun;27(3):248-258. doi: 10.1007/s11102-024-01385-0. Epub 2024 Mar 14.
3
Research progress on the role of the Wnt signaling pathway in pituitary adenoma.

本文引用的文献

1
Glucose-6-phosphate dehydrogenase mosaicism as a tracer in the study of hereditary multiple trichoepithelioma.6-磷酸葡萄糖脱氢酶嵌合体作为遗传性多发性毛发上皮瘤研究中的一种示踪剂。
Am J Hum Genet. 1966 May;18(3):282-7.
2
Gene action in the X-chromosome of the mouse (Mus musculus L.).小鼠(小家鼠)X染色体上的基因作用。
Nature. 1961 Apr 22;190:372-3. doi: 10.1038/190372a0.
3
Isolation of a genomic clone partially encoding human hypoxanthine phosphoribosyltransferase.部分编码人次黄嘌呤磷酸核糖基转移酶的基因组克隆的分离
Wnt 信号通路在垂体腺瘤中作用的研究进展。
Front Endocrinol (Lausanne). 2023 Sep 14;14:1216817. doi: 10.3389/fendo.2023.1216817. eCollection 2023.
4
The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas-New Potential Therapeutic Approach-A Systematic Review.PI3K/AKT/mTOR 和 RAF/MEK/ERK 通路激活在侵袭性垂体腺瘤中的作用——新的潜在治疗方法——系统评价。
Int J Mol Sci. 2023 Jun 30;24(13):10952. doi: 10.3390/ijms241310952.
5
Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literature.生长激素型垂体腺瘤患者的血管异常:病例报告和文献系统综述。
Pituitary. 2023 Feb;26(1):132-143. doi: 10.1007/s11102-022-01291-3. Epub 2022 Dec 12.
6
The outcomes of surgical treatment via transsphenoidal approach for patients with nonfunctioning pituitary adenoma: a single institution's experience.经蝶窦入路手术治疗无功能垂体腺瘤患者的疗效:单中心经验。
Ann Med. 2022 Dec;54(1):3136-3145. doi: 10.1080/07853890.2022.2140449.
7
Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's disease.库欣病中,通过调节诺克斯(noxa)逃避细胞凋亡,导致垂体腺瘤的发生。
Cell Rep. 2022 Aug 23;40(8):111223. doi: 10.1016/j.celrep.2022.111223.
8
Collision Tumor in the Pituitary, Concurrent Pituitary Adenoma, and Craniopharyngioma.垂体碰撞瘤,合并垂体腺瘤和颅咽管瘤。
Case Rep Otolaryngol. 2020 Sep 8;2020:9584090. doi: 10.1155/2020/9584090. eCollection 2020.
9
Pituispheres Contain Genetic Variants Characteristic to Pituitary Adenoma Tumor Tissue.垂体小体含有特征性的垂体腺瘤肿瘤组织的遗传变异。
Front Endocrinol (Lausanne). 2020 May 22;11:313. doi: 10.3389/fendo.2020.00313. eCollection 2020.
10
Identification of key genes in invasive clinically non-functioning pituitary adenoma by integrating analysis of DNA methylation and mRNA expression profiles.通过整合 DNA 甲基化和 mRNA 表达谱分析鉴定侵袭性临床无功能垂体腺瘤的关键基因。
J Transl Med. 2019 Dec 3;17(1):407. doi: 10.1186/s12967-019-02148-3.
Proc Natl Acad Sci U S A. 1982 Aug;79(16):5038-41. doi: 10.1073/pnas.79.16.5038.
4
Pure alpha subunit-secreting pituitary tumors.分泌纯α亚基的垂体肿瘤。
J Neurosurg. 1983 Oct;59(4):585-9. doi: 10.3171/jns.1983.59.4.0585.
5
Mammalian X-chromosome inactivation.哺乳动物X染色体失活。
Annu Rev Genet. 1983;17:155-90. doi: 10.1146/annurev.ge.17.120183.001103.
6
Differential methylation of hypoxanthine phosphoribosyltransferase genes on active and inactive human X chromosomes.人类活跃和失活X染色体上次黄嘌呤磷酸核糖基转移酶基因的差异甲基化
Proc Natl Acad Sci U S A. 1984 Mar;81(6):1759-63. doi: 10.1073/pnas.81.6.1759.
7
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.一种将DNA限制性内切酶片段放射性标记至高比活度的技术。
Anal Biochem. 1983 Jul 1;132(1):6-13. doi: 10.1016/0003-2697(83)90418-9.
8
Pure alpha-secreting pituitary adenomas.纯促分泌素垂体腺瘤
N Engl J Med. 1981 May 21;304(21):1254-9. doi: 10.1056/NEJM198105213042102.
9
Pituitary adenomas. An immunohistochemical study of hormone production and chromogranin localization.垂体腺瘤。激素分泌与嗜铬粒蛋白定位的免疫组织化学研究。
Am J Pathol. 1984 Sep;116(3):464-72.
10
Multiple cell origin of hereditary neurofibromas.遗传性神经纤维瘤的多细胞起源
N Engl J Med. 1971 Feb 11;284(6):298-300. doi: 10.1056/NEJM197102112840604.